Clinical trials
Fatigue trials in Spain with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 6 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Unknown status | 12 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universidad de Granada | 4 |
| University of Vic - Central University of Catalonia | 3 |
| Bionos Biotech S.L. | 2 |
| Fundacin Biomedica Galicia Sur | 2 |
| Hospital Clinic of Barcelona | 2 |
| Hospital San Carlos, Madrid | 2 |
| Hospital Universitari Vall d'Hebron Research Institute | 2 |
| Universidad Católica San Antonio de Murcia | 2 |
| Universidad de Almeria | 2 |
| University of Malaga | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatigue | 53 |
| Anxiety Disorders | 7 |
| COVID-19 | 7 |
| Multiple Sclerosis | 7 |
| Post-Acute COVID-19 Syndrome | 6 |
| Fibromyalgia | 5 |
| Breast Neoplasms | 4 |
| Neoplasms | 4 |
| Pain | 4 |
| Cognitive Dysfunction | 3 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.